6-40392461-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000338305.7(LRFN2):c.1852G>A(p.Ala618Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000389 in 1,567,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A618S) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000338305.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRFN2 | NM_020737.3 | c.1852G>A | p.Ala618Thr | missense_variant | 3/3 | ENST00000338305.7 | NP_065788.1 | |
LRFN2 | XM_011514762.3 | c.1852G>A | p.Ala618Thr | missense_variant | 3/3 | XP_011513064.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRFN2 | ENST00000338305.7 | c.1852G>A | p.Ala618Thr | missense_variant | 3/3 | 1 | NM_020737.3 | ENSP00000345985 | P1 | |
LRFN2 | ENST00000700335.1 | c.1852G>A | p.Ala618Thr | missense_variant | 4/4 | ENSP00000514953 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000671 AC: 11AN: 163930Hom.: 0 AF XY: 0.0000335 AC XY: 3AN XY: 89664
GnomAD4 exome AF: 0.0000417 AC: 59AN: 1415150Hom.: 0 Cov.: 34 AF XY: 0.0000500 AC XY: 35AN XY: 700296
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152366Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.1852G>A (p.A618T) alteration is located in exon 3 (coding exon 2) of the LRFN2 gene. This alteration results from a G to A substitution at nucleotide position 1852, causing the alanine (A) at amino acid position 618 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at